Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: The prognostic value of EGFR and KRAS mutations in resected non-small cell lung cancer (NSCLC) has been reported. However, conflicting results were reported in these studies. The effect of mutations in these two genes in resected NSCLC remains controversial. METHODS: We searched Internet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shi-Ming, Zhu, Qing-Ge, Ding, Xiao-Xiao, Lin, Song, Zhao, Jing, Guan, Lei, Li, Ting, He, Bing, Zhang, Hu-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138965/
https://www.ncbi.nlm.nih.gov/pubmed/30237741
http://dx.doi.org/10.2147/CMAR.S167578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138965/
https://www.ncbi.nlm.nih.gov/pubmed/30237741
http://dx.doi.org/10.2147/CMAR.S167578

Ejemplares similares